SPY002-091

· Spyre Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPY002-091, covering 2025-08-17 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SPY002-091 in Healthy Volunteers [Phase 1]